UBS Group’s CapForce IBD 50 ETF FFTY Stock Holding History

UBS Group’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-19,800	Closed	-$554K	–	8062
2020 Q1	$554K	Buy	19,800 +200	+1%	+$6.66K	﹤0.01%	3859
2019 Q4	$681K	Buy	+19,600	New	+$663K	﹤0.01%	4561
2018 Q3	–	Sell	-100	Closed	-$4K	–	8063
2018 Q2	$4K	Hold	100	–	–	﹤0.01%	7540
2018 Q1	$3K	Buy	+100	New	+$3.4K	﹤0.01%	7419

Other funds holding FFTY

CPA

Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CFP

Comprehensive Financial Planning East Petersburg, Pennsylvania $144M AUM 25.61% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DSCM

Del-Sette Capital Management Schenectady, New York $167M AUM 38.06% 1-Year Est. Return

UBS Group's FFTY Position: Q1 2026 in Review

UBS Group reduced its CapForce IBD 50 ETF (FFTY) stake by 76% in Q1 2026, selling an estimated $385K and leaving 3,214 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #6970.

UBS Group first reported a position in FFTY in Q3 2015 and has held it in 43 quarters since. The position peaked at $22.1M in Q3 2018. 39 funds tracked by Wall St. Rank hold FFTY as of Q1 2026.

UBS Group held 3,214 shares of CapForce IBD 50 ETF worth $107K as of Q1 2026.
UBS Group sold 10,356 CapForce IBD 50 ETF shares in Q1 2026, an estimated $385K.
CapForce IBD 50 ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6970 holding.
UBS Group first reported a position in CapForce IBD 50 ETF in Q3 2015 and has held it in 43 quarters since.
UBS Group's CapForce IBD 50 ETF position peaked at $22.1M in Q3 2018.
39 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.